Yt90 Zevalin and Combination Chemotherapy (Z-CHOP)in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-cell Lymphoma

NCT00386321 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Participants are no longer being examined or treated.

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG: Yttrium 90 -labeled ibritumomab tiuxetan (Zevalin)

Sponsor

Chulalongkorn University

Collaborators

[object Object]